- Home
- XTLB vs PPBT Comparison
XTLB vs PPBT Comparison
Compare XTLB & PPBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XTLB
- PPBT
- Stock Information
- Founded
- XTLB 1993
- PPBT 2010
- Country
- XTLB Israel
- PPBT Israel
- Employees
- XTLB N/A
- PPBT N/A
- Industry
- XTLB Biotechnology: Pharmaceutical Preparations
- PPBT Biotechnology: Pharmaceutical Preparations
- Sector
- XTLB Health Care
- PPBT Health Care
- Exchange
- XTLB Nasdaq
- PPBT Nasdaq
- Market Cap
- XTLB 7.8M
- PPBT 8.8M
- IPO Year
- XTLB 2005
- PPBT N/A
- Fundamental
- Price
- XTLB $1.76
- PPBT $3.87
- Analyst Decision
- XTLB
- PPBT Strong Buy
- Analyst Count
- XTLB 0
- PPBT 2
- Target Price
- XTLB N/A
- PPBT $126.50
- AVG Volume (30 Days)
- XTLB 12.8K
- PPBT 2.7M
- Earning Date
- XTLB 02-20-2025
- PPBT 11-15-2024
- Dividend Yield
- XTLB N/A
- PPBT N/A
- EPS Growth
- XTLB N/A
- PPBT N/A
- EPS
- XTLB N/A
- PPBT N/A
- Revenue
- XTLB N/A
- PPBT N/A
- Revenue This Year
- XTLB N/A
- PPBT N/A
- Revenue Next Year
- XTLB N/A
- PPBT N/A
- P/E Ratio
- XTLB N/A
- PPBT N/A
- Revenue Growth
- XTLB N/A
- PPBT N/A
- 52 Week Low
- XTLB $0.77
- PPBT $2.00
- 52 Week High
- XTLB $4.99
- PPBT $20.60
- Technical
- Relative Strength Index (RSI)
- XTLB 50.14
- PPBT 45.64
- Support Level
- XTLB $1.42
- PPBT $3.31
- Resistance Level
- XTLB $1.83
- PPBT $4.22
- Average True Range (ATR)
- XTLB 0.13
- PPBT 0.65
- MACD
- XTLB -0.02
- PPBT -0.12
- Stochastic Oscillator
- XTLB 53.13
- PPBT 0.75
About XTLB XTL Biopharmaceuticals Ltd.
XTL Biopharmaceuticals Ltd is engaged in the development of therapeutics for the treatment of unmet medical needs. Its products include hCDR1 and Recombinant Human Erythropoietin (rHuEPO). hCDR1 is a Phase II-ready asset compound, working through a mechanism of action, for the treatment of Systemic Lupus Erythematosus (SLE) and Sjogren's syndrome. hCDR1 is a synthetic peptide that includes approximately 20 amino-acid residues. rHuEPO, a known agent for anemia, is being developed to prolong the survival of patients with advanced multiple myeloma (MM). rHuEPO is used in clinical practice for the treatment of various anemias, including anemia of kidney disease and cancer-related anemia.
About PPBT Purple Biotech Ltd.
Purple Biotech Ltd is a clinical-stage company focused on advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, and to create treatments for people with cancer. Its oncology pipeline includes NT219 and CM24.